Product Hopping-An Expensive and Wasteful Practice

Jennifer D Claytor^{1

2}, Rita F Redberg^{3

4}

Affiliations

¹ Department of Internal Medicine, University of California, San Francisco, San Francisco.
² Editorial Fellow, JAMA Internal Medicine.
³ Division of Cardiology, Department of Internal Medicine, University of California, San Francisco, San Francisco.
⁴ Editor, JAMA Internal Medicine.

Editorial

Jennifer D Claytor et al. JAMA Intern Med. 2020.

. 2020 Sep 1;180(9):1154-1155.

doi: 10.1001/jamainternmed.2020.2736.

Jennifer D Claytor^{1

2}, Rita F Redberg^{3

4}

¹ Department of Internal Medicine, University of California, San Francisco, San Francisco.
² Editorial Fellow, JAMA Internal Medicine.
³ Division of Cardiology, Department of Internal Medicine, University of California, San Francisco, San Francisco.
⁴ Editor, JAMA Internal Medicine.

No abstract available

Comment on

Uptake of Infliximab Biosimilars Among the Medicare Population.
Chen AJ, Gascue L, Ribero R, Van Nuys K. Chen AJ, et al. JAMA Intern Med. 2020 Sep 1;180(9):1255-1256. doi: 10.1001/jamainternmed.2020.3188. JAMA Intern Med. 2020. PMID: 32702080 Free PMC article.
US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.
Rome BN, Tessema FA, Kesselheim AS. Rome BN, et al. JAMA Intern Med. 2020 Sep 1;180(9):1165-1172. doi: 10.1001/jamainternmed.2020.2771. JAMA Intern Med. 2020. PMID: 32897384 Free PMC article.